Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra low dose levonorgestrel intrauterine system (LCS) contraception study
2007-000420-40Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of avatrombopag (2 arms), sponsored by Bayer. Primary endpoint: Pregnancy rate. Started Jun 2007; status: completed.
02
Drugs
avatrombopag
Beyond the preview
Go deeper on 2007-000420-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000420-40.